{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T03:52:19Z","timestamp":1791604339228,"version":"4.3.4"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.breast.2026.104944","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:10:09Z","timestamp":1791389409000},"page":"104944","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Belgian validation of the INFLUENCE 3.0 model predicting 5-year locoregional and contralateral breast cancer recurrence"],"prefix":"10.1016","volume":"90","author":[{"given":"Aline van der","family":"Vorst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlijn","family":"Grimberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5708-2559","authenticated-orcid":false,"given":"Marissa C.","family":"van Maaren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom A.","family":"Hueting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Weltens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Siesling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina G.M.","family":"Groothuis-Oudshoorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2026.104944_bib1","unstructured":"Cancer fact sheet breast cancer, 2023 | Belgian Cancer Registry [Internet]. [cited 2025 Nov 26]. Available from: https:\/\/kankerregister.org\/en\/publicaties\/cancer-fact-sheet-breast-cancer-2023."},{"issue":"2","key":"10.1016\/j.breast.2026.104944_bib2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.annonc.2023.11.016","article-title":"Early breast cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"35","author":"Loibl","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.breast.2026.104944_bib3","doi-asserted-by":"crossref","DOI":"10.1200\/JCO-26-01700","article-title":"Breast cancer Follow-Up and surveillance after primary treatment: ASCO guideline update","author":"Nahleh","year":"2026","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.breast.2026.104944_bib4","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10549-015-3490-4","article-title":"Personalisation of breast cancer follow-up: a time-dependent prognostic nomogram for the estimation of annual risk of locoregional recurrence in early breast cancer patients","volume":"152","author":"Witteveen","year":"2015","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.breast.2026.104944_bib5","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1054\/ejon.2000.0092","article-title":"A preliminary study of patients' perceptions of routine follow-up after treatment for breast cancer","volume":"4","author":"Pennery","year":"2000","journal-title":"Eur J Oncol Nurs"},{"issue":"11\u201312","key":"10.1016\/j.breast.2026.104944_bib6","first-page":"601","article-title":"Psychological effects of routine follow up on cancer patients after surgery","volume":"159","author":"Kiebert","year":"1993","journal-title":"Eur J Surg"},{"issue":"3","key":"10.1016\/j.breast.2026.104944_bib7","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s10549-012-2297-9","article-title":"Pattern of follow-up care and early relapse detection in breast cancer patients","volume":"136","author":"Geurts","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2026.104944_bib8","first-page":"79","article-title":"The INFLUENCE 3.0 model: updated predictions of locoregional recurrence and contralateral breast cancer, now also suitable for patients treated with neoadjuvant systemic therapy","author":"Van Maaren","year":"2025","journal-title":"Breast"},{"issue":"2","key":"10.1016\/j.breast.2026.104944_bib9","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10549-024-07246-5","article-title":"Opportunities for personalised follow-up in breast cancer: the gap between daily practice and recurrence risk","volume":"205","author":"Voets","year":"2024","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2026.104944_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2024.103829","article-title":"The INFLUENCE 3.0 model: updated predictions of locoregional recurrence and contralateral breast cancer, now also suitable for patients treated with neoadjuvant systemic therapy","volume":"79","author":"Van Maaren","year":"2025","journal-title":"Breast"},{"issue":"3","key":"10.1016\/j.breast.2026.104944_bib11","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s10549-021-06335-z","article-title":"Improved risk estimation of locoregional recurrence, secondary contralateral tumors and distant metastases in early breast cancer: the INFLUENCE 2.0 model","volume":"189","author":"V\u00f6lkel","year":"2021","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2026.104944_bib12","unstructured":"Influence 3.0: risk of locoregional recurrence, secondary contralateral tum - evidencio [Internet]. [cited 2025 Sep 3]. Available from: https:\/\/www.evidencio.com\/models\/show\/2238."},{"issue":"1","key":"10.1016\/j.breast.2026.104944_bib13","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-023-11504-y","article-title":"Personalized surveillance and aftercare for non-metastasized breast cancer: the NABOR study protocol of a multiple interrupted time series design","volume":"23","author":"Klaassen-Dekker","year":"2023","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.breast.2026.104944_bib14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/ckj\/sfaa188","article-title":"External validation of prognostic models: what, why, how, when and where?","volume":"14","author":"Ramspek","year":"2021","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.breast.2026.104944_bib15","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.breast.2023.01.006","article-title":"The use and misuse of risk prediction tools for clinical decision-making","volume":"69","author":"van Maaren","year":"2023","journal-title":"Breast"},{"issue":"1","key":"10.1016\/j.breast.2026.104944_bib16","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12916-023-02779-w","article-title":"There is no such thing as a validated prediction model","volume":"21","author":"Van Calster","year":"2023","journal-title":"BMC Med"},{"key":"10.1016\/j.breast.2026.104944_bib17","article-title":"Evaluation of clinical prediction models (part 2): how to undertake an external validation study","volume":"384","author":"Riley","year":"2024","journal-title":"Br Med J"},{"issue":"12","key":"10.1016\/j.breast.2026.104944_bib18","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju288","article-title":"Maastricht Delphi consensus on event definitions for classification of recurrence in breast cancer research","volume":"106","author":"Moossdorff","year":"2014","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"10.1016\/j.breast.2026.104944_bib19","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1002\/sim.2712","article-title":"Tutorial in biostatistics: competing risks and multi-state models","volume":"26","author":"Putter","year":"2007","journal-title":"Stat Med"},{"key":"10.1016\/j.breast.2026.104944_bib20","series-title":"Mice: multivariate imputation by chained equations [Internet]","author":"Buuren","year":"2024"},{"issue":"21","key":"10.1016\/j.breast.2026.104944_bib21","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1002\/sim.8570","article-title":"Graphical calibration curves and the integrated calibration index (ICI) for survival models","volume":"39","author":"Austin","year":"2020","journal-title":"Stat Med"},{"key":"10.1016\/j.breast.2026.104944_bib22","unstructured":"Sawyer S. The greenwood and exponential greenwood confidence intervals in survival analysis [Internet]. Available from:: https:\/\/www.math.wustl.edu\/\u223csawyer\/handouts\/greenwood.pdf."},{"issue":"12","key":"10.1016\/j.breast.2026.104944_bib23","doi-asserted-by":"crossref","first-page":"e853","DOI":"10.1016\/S2589-7500(22)00188-1","article-title":"Interpreting area under the receiver operating characteristic curve","volume":"4","author":"Hond","year":"2022","journal-title":"Lancet Digit Health"},{"key":"10.1016\/j.breast.2026.104944_bib24","series-title":"Flexible imputation of missing data","first-page":"444","author":"Van Buuren","year":"2021"},{"key":"10.1016\/j.breast.2026.104944_bib25","series-title":"Chapter9 Rubin's Rules | Book_MI","year":"2025"},{"issue":"7","key":"10.1016\/j.breast.2026.104944_bib26","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/sim.9275","article-title":"Minimum sample size calculations for external validation of a clinical prediction model with a time-to-event outcome","volume":"41","author":"Riley","year":"2022","journal-title":"Stat Med"},{"issue":"5","key":"10.1016\/j.breast.2026.104944_bib27","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3748\/wjg.v28.i5.605","article-title":"Machine learning models and over-fitting considerations","volume":"28","author":"Charilaou","year":"2022","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.breast.2026.104944_bib28","series-title":"Multivariate statistical machine learning methods for genomic prediction [Internet]","first-page":"109","article-title":"Overfitting, model tuning, and evaluation of prediction performance","author":"Montesinos L\u00f3pez","year":"2022"},{"key":"10.1016\/j.breast.2026.104944_bib29","series-title":"Statistics for biology and health [Internet]","article-title":"Clinical prediction models: a practical approach to development, validation, and updating","author":"Steyerberg","year":"2019"},{"issue":"7","key":"10.1016\/j.breast.2026.104944_bib30","doi-asserted-by":"crossref","DOI":"10.1007\/s00432-019-02904-4","article-title":"Predicting the risk of locoregional recurrence after early breast cancer: an external validation of the Dutch INFLUENCE-nomogram with clinical cancer registry data from Germany","volume":"145","author":"Voelkel","year":"2019","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"10.1016\/j.breast.2026.104944_bib31","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12916-019-1466-7","article-title":"Calibration: the achilles heel of predictive analytics","volume":"17","author":"Van Calster","year":"2019","journal-title":"BMC Med"},{"issue":"12_Supplement","key":"10.1016\/j.breast.2026.104944_bib32","doi-asserted-by":"crossref","DOI":"10.1158\/1557-3265.SABCS24-P3-12-06","article-title":"Abstract P3-12-06: locoregional and contralateral breast tumor events within 5 years after diagnosis of primary breast cancer in the Netherlands: a population-based study including 121,426 breast cancer patients","volume":"31","author":"Siesling","year":"2025","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.breast.2026.104944_bib33","doi-asserted-by":"crossref","DOI":"10.1186\/s12874-017-0332-6","article-title":"Time-dependent ROC curve analysis in medical research: current methods and applications","volume":"17","author":"Kamarudin","year":"2017","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"10.1016\/j.breast.2026.104944_bib34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13058-022-01567-3","article-title":"PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in \u223c 200,000 patients","volume":"24","author":"Giardiello","year":"2022","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.breast.2026.104944_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.breast.2018.11.005","article-title":"Risk factors for metachronous contralateral breast cancer: a systematic review and meta-analysis","volume":"44","author":"Akdeniz","year":"2019","journal-title":"Breast"},{"issue":"8","key":"10.1016\/j.breast.2026.104944_bib36","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.ejso.2013.05.004","article-title":"Prognosis following local recurrence after breast conserving treatment in young women with early breast cancer","volume":"39","author":"Sangen","year":"2013","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"10.1016\/j.breast.2026.104944_bib37","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1007\/s11845-024-03809-z","article-title":"Risk of locoregional recurrence after breast cancer surgery by molecular subtype-a systematic review and network meta-analysis","volume":"193","author":"Nolan","year":"2024","journal-title":"Ir J Med Sci"},{"issue":"54","key":"10.1016\/j.breast.2026.104944_bib38","doi-asserted-by":"crossref","first-page":"30355","DOI":"10.18632\/oncotarget.25735","article-title":"Risk factors for loco-regional recurrence in breast cancer patients: a retrospective study","volume":"9","author":"Merino","year":"2018","journal-title":"Oncotarget"},{"issue":"14","key":"10.1016\/j.breast.2026.104944_bib39","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1002\/cncr.31518","article-title":"Risk factors for locoregional disease recurrence after breast-conserving therapy in patients with breast cancer treated with neoadjuvant chemotherapy: an international collaboration and individual patient meta-analysis","volume":"124","author":"Valachis","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2026.104944_bib40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.clinimag.2021.06.032","article-title":"Mode of detection matters: differences in screen-detected versus symptomatic breast cancers","volume":"80","author":"Starikov","year":"2021","journal-title":"Clin Imag"},{"issue":"7","key":"10.1016\/j.breast.2026.104944_bib41","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1200\/JCO.2005.06.052","article-title":"Site of primary tumor has a prognostic role in operable breast cancer: the international breast cancer study group experience","volume":"23","author":"Colleoni","year":"2005","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.breast.2026.104944_bib42","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/jamaoncol.2016.3031","article-title":"Prognostic factors for local control in breast cancer after long-term Follow-up in the EORTC boost vs no boost trial: a randomized clinical trial","volume":"3","author":"Vrieling","year":"2017","journal-title":"JAMA Oncol"},{"issue":"9","key":"10.1016\/j.breast.2026.104944_bib43","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20181853","article-title":"Can a subgroup at high risk for LRR be identified from T1-2 breast cancer with negative lymph nodes after mastectomy? A meta-analysis","volume":"39","author":"Peng","year":"2019","journal-title":"Biosci Rep"},{"issue":"3","key":"10.1016\/j.breast.2026.104944_bib44","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ijrobp.2013.11.012","article-title":"Society of surgical oncology\u2013american society for radiation oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer","volume":"88","author":"Moran","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.breast.2026.104944_bib45","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1245\/s10434-014-3480-5","article-title":"The association of surgical margins and local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy: a meta-analysis","volume":"21","author":"Houssami","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.breast.2026.104944_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/s41523-025-00850-8","article-title":"Evaluation of methods to classify ipsilateral breast tumour recurrences as local recurrence or new primary tumour","volume":"12","author":"Blacker","year":"2026","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.breast.2026.104944_bib47","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.breast.2018.03.011","article-title":"Incidence of isolated local breast cancer recurrence and contralateral breast cancer: a systematic review","volume":"39","author":"Spronk","year":"2018","journal-title":"Breast"},{"key":"10.1016\/j.breast.2026.104944_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2025.103883","article-title":"Incidence and temporal patterns of true recurrences and second primaries in women with breast cancer: a 10-year competing risk-adjusted analysis","volume":"80","author":"Mancini","year":"2025","journal-title":"Breast"},{"issue":"25","key":"10.1016\/j.breast.2026.104944_bib49","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1200\/JCO.20.00818","article-title":"Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial","volume":"38","author":"Palma","year":"2020","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.breast.2026.104944_bib50","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10549-008-0023-4","article-title":"Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis","volume":"114","author":"Lu","year":"2009","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"10.1016\/j.breast.2026.104944_bib51","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/annonc\/mdy192","article-title":"4th ESO\u2013ESMO international consensus guidelines for advanced breast cancer (ABC 4)","volume":"29","author":"Cardoso","year":"2018","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.breast.2026.104944_bib52","doi-asserted-by":"crossref","first-page":"e1330","DOI":"10.1634\/theoncologist.2019-0973","article-title":"Evaluating the age-based recommendations for long-term Follow-Up in breast cancer","volume":"25","author":"Witteveen","year":"2020","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.breast.2026.104944_bib53","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-023-11504-y","article-title":"Personalized surveillance and aftercare for non-metastasized breast cancer: the NABOR study protocol of a multiple interrupted time series design","volume":"23","author":"Klaassen-Dekker","year":"2023","journal-title":"BMC Cancer"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977626002547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977626002547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T03:23:38Z","timestamp":1791602618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977626002547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":53,"alternative-id":["S0960977626002547"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2026.104944","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Belgian validation of the INFLUENCE 3.0 model predicting 5-year locoregional and contralateral breast cancer recurrence","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2026.104944","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104944"}}